Glenmark Pharmaceuticals Limited (GLENMARK.NS) - Stock Prices, Stock Peers & Analysis

Home
GLENMARK.NS

Company Name	Glenmark Pharmaceuticals Limited
Symbol	GLENMARK.NS
Currency	INR
Price	1,702.7
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	480,481,507,600
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0.25%
52-week-range	722.1 - 1,750.5
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Mr. Glenn Mario Saldanha
Website	https://www.glenmarkpharma.com

An error occurred while fetching data.

About Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, North America, Latin America, Europe, and internationally. The company provides branded and generic formulations in the therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its product pipeline includes ISB 830 (telazorlimab),